Skip to main content
Caplight Logo









BayVax Biotech Limited

BayVax Biotech Limited

Private
Hong KongHealthcare & Life Scienceshttps://www.bayvaxbio.com/

Last Round

Grant

Jul 1, 2023

Company Overview

BayVax Biotech Limited operates in Healthcare & Life Sciences and is based in Hong Kong. Its latest recorded funding round was a Grant round in July 2023.

BayVax Biotech Limited is a biopharmaceutical company that develops synthetic vaccines and AI-driven computational immunology platforms for treating cancers and immune-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BayVax Biotech Limited Comparables

Compare BayVax Biotech Limited with similar companies based on industry and business-model similarity.

BayVax Biotech Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deepflare
83%
Synteny
81%
BioLM
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BayVax Biotech Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

BayVax Biotech Limited Investors

Notable investors and investment history

BayVax Biotech Limited investors
InvestorRounds
Hong Kong Science and Technology Parks CorporationAccelerator
MiraclePlusAccelerator

BayVax Biotech Limited Filings

Explore SEC and related filing metadata, where available.

BayVax Biotech Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BayVax Biotech Limited's valuation, stock price, and market status.

Is BayVax Biotech Limited a public or private company?

BayVax Biotech Limited is a private company.

What is the current stock price of BayVax Biotech Limited?

BayVax Biotech Limited is a private company, so its shares have no public market price. Caplight tracks BayVax Biotech Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BayVax Biotech Limited worth (valuation)?

Valuation information for BayVax Biotech Limited is not publicly available.

Can I buy BayVax Biotech Limited stock?

BayVax Biotech Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BayVax Biotech Limited's last funding round?

BayVax Biotech Limited's most recent funding round was Grant on July 1, 2023.

Who are the main investors in BayVax Biotech Limited?

Key investors in BayVax Biotech Limited include Hong Kong Science and Technology Parks Corporation, MiraclePlus.

Will BayVax Biotech Limited IPO soon?

No public IPO plans have been announced for BayVax Biotech Limited.

How can I track BayVax Biotech Limited secondary market activity?

Caplight tracks bids, offers, and trades in BayVax Biotech Limited's shares on secondary markets.

Firmographic Details

HeadquartersHong Kong
Year FoundedN/A
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?